日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer

AMEERA-3：一项随机II期研究，比较口服选择性雌激素受体降解剂安西那群与标准内分泌单药疗法在雌激素受体阳性、人表皮生长因子受体2阴性晚期乳腺癌患者中的疗效

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.22.02746
Tolaney, Sara M; Chan, Arlene; Petrakova, Katarina; Delaloge, Suzette; Campone, Mario; Iwata, Hiroji; Peddi, Parvin F; Kaufman, Peter A; De Kermadec, Elisabeth; Liu, Qianying; Cohen, Patrick; Paux, Gautier; Wang, Lei; Ternès, Nils; Boitier, Eric; Im, Seock-Ah
肿瘤
肿瘤免疫
信号转导
乳腺癌
Human
免疫/内分泌
发表日期：2023
文献求助 收藏

Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus

一项针对接受依维莫司治疗的激素受体阳性乳腺癌女性患者的非甾体类漱口水预防和治疗口腔炎的II期随机试验

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/1758835920967259
Peddi, Parvin F; Tetef, Merry; Coluzzi, Paul; Arzoo, Karo K; Hu, Eddie H; Berkowitz, Maurice J; Chan, David; Moore, Dennis Jr; Adams, Brad; Wang, Xiaoyan; Hurvitz, Sara A
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2020
文献求助 收藏

Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential

Ado-曲妥珠单抗-美坦新（T-DM1）在人表皮生长因子受体2（HER2）阳性转移性乳腺癌中的应用：最新证据和临床潜力

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/1758834014539183
Peddi, Parvin F; Hurvitz, Sara A
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
发表日期：2014
文献求助 收藏

PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer

PI3K通路抑制剂用于治疗脑转移瘤，重点关注HER2阳性乳腺癌

期刊:Journal of Neuro-Oncology
影响因子:3.1
doi:10.1007/s11060-014-1369-6
Peddi, Parvin F; Hurvitz, Sara A
肿瘤
HER2
肿瘤免疫
信号转导
神经科学
乳腺癌
发表日期：2014
文献求助 收藏

Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma

维生素D缺乏与胰腺腺癌患者的预后

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/1479-5876-11-206
Cho, May; Peddi, Parvin F; Ding, Kevin; Chen, Ling; Thomas, Denise; Wang, Jian; Lockhart, Albert C; Tan, Benjamin; Wang-Gillam, Andrea
肿瘤
肿瘤免疫
发表日期：2013
文献求助 收藏

Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer

曲妥珠单抗-美坦新：首个用于治疗乳腺癌的靶向化疗药物

期刊:Future Oncology
影响因子:2.6
doi:10.2217/fon.13.7
Peddi, Parvin F; Hurvitz, Sara A
肿瘤免疫
肿瘤
乳腺癌
发表日期：2013
文献求助 收藏

Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma

难治性胰腺腺癌的白蛋白结合型紫杉醇单药治疗

期刊:Journal of Gastrointestinal Oncology
影响因子:2
doi:10.3978/j.issn.2078-6891.2013.034
Peddi, Parvin F; Cho, May; Wang, Jian; Gao, Feng; Wang-Gillam, Andrea
肿瘤
肿瘤免疫
发表日期：2013
文献求助 收藏